Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Metalsguy1on Dec 10, 2020 4:24am
144 Views
Post# 32074755

RE:RE:RE:RE:RE:Sigilon

RE:RE:RE:RE:RE:Sigilon
I think the main point is that prior decisions and questionable financing practices have indeed cast a shadow over SVA. A hundred million puts others in a Ferrari heading for a huge payoff, while Sernova is puttering down the road in a Yugo with 5 patients strapped to the roof. Consider this. Clearly Lilly et al have a very high level of confidence in Sigilon. If they got taken out like Semma at $1 billion, that would put them at 40 a share, which would be roughly 4.50 us a share adjusted for SVA's massive float. And..you can probably add to that when Sigulon starts making progress quickly with a 100 million tank of gas. Personally I would not complain in the least if there was a move afoot by big investors to call for a special election to oust Frank Holler and any or all of his cronies. I have never seen a more useless and self serving Board of Directors. One more long term deal that happens in the shadows where pouches are provided with no investment in the company could mean a gasping crawl towards a finish line that will already have been crossed by others.
<< Previous
Bullboard Posts
Next >>